- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
NIST grant to fund wireless implant research
NIST grant to fund wireless implant researchThe National Institute of Standards and Technology’s Advanced Technology Program has awarded $1.98 million to Integrated Sensing Systems (ISSYS) to develop wireless, batteryless microfabricated
NIST grant to fund wireless implant research
The National Institute of Standards and Technologys Advanced Technology Program has awarded $1.98 million to Integrated Sensing Systems (ISSYS) to develop wireless, batteryless microfabricated pressure sensors. ISSYS is working on sensors that can provide continuous monitoring of biologic fluid pressures while implanted in the body. Initially, the sensors will be used for hydrocephalus and glaucoma.
The Ypsilanti, MI-based firm produces a pressure sensor the size of a grain of rice, and it intends to extend that products capabilities to a single, self-contained unit that will be powered and read by an external radio-frequency transceiver. The handheld transceiver will be able to detect sensor readings from up to six inches away. The University of Michigans Kellogg Eye Center and the Cleveland Clinic Foundation have agreed to test the products. ISSYS estimates that the devices can save more than $1.5 billion annually in medical testing and treatment.
- Search Again
- Return To HNN Homepage
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
CT Study Links Pleural Effusion and Higher 30-Day Mortality Rates in Patients with COVID-19
October 1st 2024In a multicenter study of over 1,100 patients with COVID-19, pleural effusion was detected on CT scans in nearly a third of patients, who also had significantly higher ICU admission and 30-day mortality rates.
